One patient was excluded due to severe depression, 15 patients met the criteria for PDD (30.6%) and 18 for PD-MCI (36.7%). Results: A total of 50 patients with PD were evaluated. MOCA and MMSE were applied to all patients by an investigator blinded to the “Gold Standard” results.

Patients underwent a comprehensive neurological and neuropsychological assessment (gold standard) in order to classify them in PD with dementia (PDD), PD with mild cognitive impairment (PD-MCI) (level II of MDS criteria) and PD without cognitive disorder. Inclusion criteria were patients aged between 45 and 80 years with diagnosis of PD and Hoehn & Yahr stage 1-4. Methods: Prospective cross-sectional diagnostic accuracy study conducted in 50 consecutive patients at one center in Bogotá, Colombia. There are not previous studies in Latin America. However, the sensitivity and specificity, as well as the cutoffs for detecting dementia and mild cognitive impairment in PD differ across studies, probably due to variability of populations. Secondary objectives were to identify potential cutoffs for MOCA in this population and compare MOCA with Minimental State Examination (MMSE) scores as screening tools for cognitive deficits in PD.īackground: MOCA is widely used as screening tool for cognitive impairment in PD. Objective: To determine the discriminant ability of the Montreal Cognitive Assessment (MOCA) for detection of dementia or any cognitive impairment in patients with Parkinson’s disease (PD) from a tertiary referral hospital in Colombia. Location: Exhibit Hall located in Hall B, Level 2

Moca score cutoffs